Skip to main content

COVID-19 Hospitalizations Tank a Month After Vaccines Roll Out

Two preliminary reports from the UK provide real-world evidence in support of the Pfizer/BioNTech and Oxford-AstraZeneca vaccines.

Written byAsher Jones
| 2 min read
COVID-19, coronavirus, SARS-CoV-2, pandemic, virus, vaccine, vaccination, Pfizer, AstraZeneca

Register for free to listen to this article
Listen with Speechify
0:00
2:00

ABOVE: © ISTOCK.COM, GEMPHOTOGRAPHY

New results from England- and Scotland-based studies suggest that the UK’s COVID-19 vaccination program is effective at reducing hospitalizations and the risk of contracting the disease.

Preliminary findings from a study of the Scottish population found that there were 85 percent fewer hospital admissions for people who received the first dose of the Pfizer/BioNTech vaccine four weeks prior compared with those who were unvaccinated. Similarly, one shot of Oxford/AstraZeneca’s version was tied to a reduction in hospitalizations of up 94 percent, according to the Associated Press. The results, which have not yet undergone peer review, were posted to The Lancet’s preprint site on February 19.

A second study, which was posted to The Lancet’s preprint site on February 22, of health care workers in England found that one shot of Pfizer’s vaccine was associated with a reduced risk of contracting the disease by 70 percent, while ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo